Balversa -4mg-US (Erdafitinib Tablet) 4mg

Balversa (erdafitinib) 4mg tablets are prescribed for adults with certain types of bladder cancer. This targeted therapy helps manage cancer progression when used as directed. Balversa is an oral medication taken at home. Seek medical guidance before starting or stopping.

Strength

4mg

Pack Size

56s

Storage

Ambient

Manufacturer / TM Owner

Janssen

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Balversa (erdafitinib) 4mg tablets are used to treat adults with locally advanced or metastatic urothelial carcinoma that has a specific FGFR3 or FGFR2 genetic alteration. This medication is prescribed when cancer has progressed during or after platinum-based chemotherapy. It works by targeting fibroblast growth factor receptors to help slow disease progression. Balversa is not a first-line treatment and is used under medical supervision.

Side Effects

Balversa (erdafitinib) 4mg tablets may cause changes in how your body processes vitamin D and phosphate, which can lead to side effects like dry mouth, increased thirst, or skin reactions. Some people notice mild nausea or fatigue while taking this medication. Your doctor will monitor blood levels regularly to manage any effects. Keep follow-up appointments to track your response to treatment.

Precautions & Warnings

Store Balversa 4mg tablets at room temperature away from moisture and heat. Keep the medication in its original blister pack until ready to use. Handle with clean, dry hands and avoid crushing or splitting tablets unless instructed. Tell your healthcare provider about all other medications and supplements you take. Use effective contraception if you or your partner could become pregnant during treatment.

Avoid Interactions

Balversa (erdafitinib) 4mg may interact with strong CYP3A4 inhibitors or inducers, which can change how your body processes the medication. Avoid grapefruit products while taking this drug, as they may increase erdafitinib levels. Some supplements, like St. John’s wort, can also affect how Balversa works. Always review your full medication list with your doctor before starting treatment.

Frequently Asked Questions

Balversa 4mg tablets are used to treat adults with advanced bladder cancer that has a specific FGFR3 or FGFR2 genetic alteration.

Store Balversa 4mg tablets at room temperature in the original blister pack, away from moisture and heat.

Review all medications and supplements with your doctor before starting Balversa, as some may interact with erdafitinib.

Common effects may include dry mouth, increased thirst, skin reactions, mild nausea, or fatigue.

Balversa (erdafitinib) is a targeted therapy, not a traditional chemotherapy drug.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.